US2015165085A1PendingUtilityA1
Treatment of leg ulcers using placenta derived collagen biofabric
Est. expiryJul 13, 2025(expired)· nominal 20-yr term from priority
A61P 29/00A61P 31/12A61P 35/00A61P 31/00A61P 31/10A61P 17/02A61L 15/40A61L 27/3604A61L 2430/40A61L 31/005A61L 2300/414A61K 38/363A61F 2013/0054A61L 2430/34A61F 13/069A61F 2013/00548A61L 27/60Y10T428/249921A61K 38/1858A61K 38/2292A61K 38/39A61F 2013/00927A61F 15/001A61F 2013/0091A61L 15/325A61K 31/728A61K 38/1841A61L 2300/252A61L 15/44A61L 26/0057A61L 15/32A61L 26/0033A61K 38/4833
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a method of treating a leg ulcer comprising contacting the leg ulcer with a collagen biofabric. The leg ulcer may be a venous, arterial, diabetic or decubitus (pressure) ulcer. The invention further provides kits comprising one or more pieces of collagen biofabric for the treatment of a leg ulcer.
Claims
exact text as granted — not AI-modified1 .- 24 . (canceled)
25 . A sterilized, decellularized, and dehydrated amnion-derived biofabric, wherein said biofabric comprises vascular-endothelial growth factor (VEGF) and fibroblast growth factor (FGF).
26 . The biofabric of claim 25 , comprising collagen, fibronectin, and proteoglycans.
27 . A pharmaceutical composition comprising the biofabric of claim 25 .
28 . A pharmaceutical composition comprising the biofabric of claim 26 .
29 . The biofabric of claim 25 , wherein said biofabric is shaped as a sheet or membrane.
30 . The biofabric of claim 29 , wherein said biofabric is shaped as a sheet.
31 . The biofabric of claim 25 , wherein said biofabric is shaped as a netting or webbing.
32 . The biofabric of claim 25 , wherein said biofabric is mounted on a support.
33 . The biofabric of claim 32 , wherein said support is a bandage.Join the waitlist — get patent alerts
Track US2015165085A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.